The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: Current status and future perspectives

Journal of Cellular Physiology

Volumn 218, Issue 1, 2009, Pages 9-12

  Abdallah, Basem M ^a,b   Kassem, Moustapha ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; BONE REGENERATION; CARTILAGE CELL; CELL DIFFERENTIATION; DEGENERATIVE DISEASE; GRAFT VERSUS HOST REACTION; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; THERAPY EFFECT; TISSUE ENGINEERING; ANIMAL; BONE DISEASE; CARDIOVASCULAR DISEASE; CELL SEPARATION; CYTOLOGY; HEMATOPOIESIS; MESENCHYMAL STEM CELL; METHODOLOGY; MULTIPOTENT STEM CELL; REVIEW; STROMA CELL; TRANSPLANTATION;

ANIMALS; BONE DISEASES; BONE REGENERATION; CARDIOVASCULAR DISEASES; CELL SEPARATION; GRAFT VS HOST DISEASE; HEMATOPOIESIS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; STROMAL CELLS; TISSUE ENGINEERING;

EID: 58149149508     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21572     Document Type: Short Survey

References (82)

1. Abdallah BM, Kassem M. 2008. Human mesenchymal stem cells: From basic biology to clinical applications. Gene Ther 15:109-116.
2. Abdallah BM, Haack-Sorensen M, Burns JS, Elsnab B,Jakob F, Hokland P, Kassem M.2005. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun 326:527-538.
3. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, Locatelli F, Fibbe WE. 2007. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110:2764-2767.
4. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, Mcintosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
5. bdel-Latif A, Bolli R,Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M,Dawn B.2007.Adultbone marrow-derived cellsforcardiacrepair:Asystematic review and meta-analysis. Arch Intern Med 167:989-997.
6. Bentzon JF, Stenderup K, Hansen FD, Schroder HD, Abdallah BM, Jensen TG, Kassem M. 2005. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene. Biochem Biophys Res Commun 330:633-640.
7. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, Montagna D, Maccario R, Villa R, Daidone MG, Zuffardi O, Locatelli F. 2007. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142-9149.
8. Bianco P, Robey PG. 2001. Stem cells in tissue engineering. Nature 414:118-121.
9. Bianco P, Riminucci M, Gronthos S, Robey PG. 2001. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192.
10. Bruder SP, Fink DJ, Caplan AI. 1994. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy 172. J Cell Biochem 56:283-294.
11. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP. 2004. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95.
12. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA. 2005. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short-and long-term effects. Circulation 112:214-223.
13. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. 2001. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44:1928-1942.
14. De Coppi P, Bartsch G, Jr., Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. 2007. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106.
15. De Kok IJ, Peter SJ, Archambault M, van den Bos C,Kadiyala S, Aukhil I, Cooper LF. 2003. Investigation of allogeneic mesenchymal stem cell-based alveolar bone formation: Preliminary findings. Clin Oral Implants Res 14:481-489.
16. Dean RM, Bishop MR. 2003. Graft-versus-host disease: Emerging concepts in prevention and therapy. Curr Hematol Rep 2:287-294.
17. Dexter TM. 1979. Haemopoiesis in long-term bone marrow cultures. A review. Acta Haematol 62:299-305.
18. Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, Tajima N, Yamada H, Sawada H, Ishikawa H, Mimura T, Kitada M, Suzuki Y, Ide C. 2004. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113:1701-1710.
19. Di NM, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
20. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
21. Foster LJ, Zeemann PA, Li C, Mann M, Jensen ON, Kassem M. 2005. Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 23:1367-1377.
22. Francois S, Bensidhoum M, Mouiseddine M, Mazurier C, Allenet B, Semont A, Frick J,Sache A, Bouchet S,Thierry D, Gourmelon P, Gorin NC, Chapel A. 2006. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites butpromotes their widespread engraftment to multiple organs: A study of their quantitative distribution after irradiation damage. Stem Cells 24:1020-1029.
23. Friedenstein AJ, Chailakhjan RK, Lalykina KS. 1970. The development of fibroblast colonies in monolayer cultures of guinea- pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403.
24. Gang EJ, Bosnakovski D,Figueiredo CA, Visser JW, Perlingeiro RC. 2007. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109:1743-1751.
25. Gangji V, Hauzeur JP. 2005. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique. J Bone Joint Surg Am 87:106-112.
26. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. 2003. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835.
27. Ho G, Leung VY, Cheung KM, Chan D. 2008. Effect of severity of intervertebral disc injury on mesenchymal stem cell-based regeneration. Connect Tissue Res 49:15-21.
28. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. 1999. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309-313.
29. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK. 2001. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97:1227-1231.
30. Horwitz EM, Gordon PL, Koo WKK, Marx JC, Neel MD, Mcnall RY, Muul L, Hofmann T. 2002. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesisimperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932-8937.
31. Humphreys BD, Bonventre JV. 2008. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 59:311-325.
32. Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ. 2007. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25:2363-2370.
33. Kassem M, Mosekilde L, Eriksen EF. 1993. 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells.J Bone Miner Res 8:1453-1458.
34. Katritsis DG, Sotiropoulou PA, Karvouni E, Karabinos I, Korovesis S, Perez SA, Voridis EM, Papamichail M. 2005. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 65:321-329.
35. Khojasteh A, Eslaminejad MR, Nazarian H. 2008. Mesenchymal stem cells enhance bone regeneration in rat calvarial critical size defects more than platelete-rich plasma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod Apr 17. [Epub ahead of print].
36. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE. 2004. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685.
37. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. 2000. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18:307-316.
38. Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M, Martin I, Boyde A, Ruspantini I, Chistolini P, Rocca M, Giardino R, Cancedda R, Quarto R. 2000. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones 10. J Biomed Mater Res 49:328-337.
39. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F. 2003. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722-3729.
40. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M. 2005. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308:1472-1477.
41. Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, Ohgushi H, Wakitani S, Kurosaka M. 2007. Treatment of a full-thickness articular cartilage defectin the femoral condyle of anathlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 15:226-231.
42. Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG. 1997. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12:1335-1347.
43. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. 2001. Circulating skeletal stem cells. J Cell Biol 153:1133-1140.
44. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Jr., Moseley AB, Bacigalupo A. 2005. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389-398.
45. Le Blanc K. 2003. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5:485-489.
46. Le Blanc K, Gotherstrom C, Ringden O, Hassan M, McMahon R, Horwitz E, Anneren G, Axelsson O, Nunn J, Ewald U, Norden-Lindeberg S, Jansson M, Dalton A, Astrom E, Westgren M. 2005. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.Transplantation 79:1607-1614.
47. Le BK, Tammik C, Rosendahl K, Zetterberg E, Ringden O. 2003. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896.
48. Lee ST, Jang JH, Cheong JW, Kim JS, Maemg HY, Hahn JS, Ko YW, Min YH. 2002. Treatment ofhigh-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of Tcell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from arelated donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol 118:1128-1131.
49. Luk JM, Wang PP, Lee CK, Wang JH, Fan ST. 2005. Hepatic potential of bone marrow stromal cells: Development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods 305:39-47.
50. Luria EA,Panasyuk AF, Friedenstein AY. 1971. Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 11:345-349.
51. Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, Koc ON. 2004. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33:597-604.
52. Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL. 2000. Humanmarrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9:841-848.
53. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S. 1999. Cardiomyocytes can be generated from marrow stromal cells in vitro 41. J Clin Invest 103:697-705.
54. Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG, Shi S. 2003. SHED: Stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100:5807-5812.
55. Miura Y, Miura M, Gronthos S, Allen MR, Cao C, Uveges TE, Bi Y, Ehirchiou D, Kortesidis A, Shi S, Zhang L. 2005. Defective osteogenesis of the stromal stem cells predisposes CDI8-null mice to osteoporosis. Proc Natl Acad Sci USA 102:14022-14027.
56. Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S. 2004. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.Am J Physiol Heart Circ Physiol 287:H2670-H2676.
57. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, Fujii T, Uematsu M, Ohgushi H, Yamagishi M, Tokudome T, Mori H, Miyatake K, Kitamura S. 2005. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112:1128-1135.
58. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V. 2008. PDGF, TGF-b and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSC into adipogenic, chondrogenic and ostoegenic lineages. Blood 112:295-307.
59. Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A, Dzau VJ, Pratt RE. 2006. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14:840-850.
60. Ohgushi H, Goldberg VM, Caplan AI.1989.Repair of bone defects with marrow cells and porous ceramic. Experiments in rats 116. Acta Orthop Scand 60:334-339.
61. Ohgushi H, Kotobuki N, Funaoka H, Machida H, Hirose M, Tanaka Y, Takakura Y. 2005. Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 26:4654-4661.
62. Penna C, Raimondo S, Ronchi G, Rastaldo R, Mancardi D, Cappello S, Losano G, Geuna S, Pagliaro P. 2008. Early homing of adult mesenchymal stem cells in normal and infarcted isolated beating hearts. J Cell Mol Med 12:507-521.
63. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells 6. Science 284:143-147.
64. Post S, Abdallah BM, Bentzon JF, Kassem M. 2008. Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bonemarrow-derived mesenchymal stem cells. Bone 43:32-39.
65. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M. 2001. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344:385-386.
66. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL. 2002. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30:783-791.
67. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. 2002. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109:337-346.
68. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. 1996. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 11:312-324.
69. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. 2006. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397.
70. Rosada C, Justesen J, Melsvik D, Ebbesen P, Kassem M. 2003. The human umbilical cord blood: A potential source for osteoblast progenitor cells. Calcif Tissue Int72: 135-142.
71. Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, Wohlgemuth R. 2008. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14:181-187.
72. Sakai D, Mochida J, Iwashina T, Hiyama A, Omi H, Imai M, Nakai T, Ando K, Hotta T. 2006. Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials 27:335-345.
73. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ. 2002. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 73:1919-1925.
74. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, Jensen TG, Kassem M. 2002. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592-596.
75. Stenderup K, Justesen J, Clausen C, Kassem M. 2003. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone33:919-926.
76. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, Ho AD. 2005. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33:1402-1416.
77. Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S. 2004. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: Two case reports. Cell Transplant 13:595-600.
78. Warnke PH, Springer IN, Wiltfang J, Acil Y, Eufinger H, Wehmoller M, Russo PA, Bolte H, Sherry E, Behrens E, Terheyden H. 2004. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364:766-770.
79. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H.2004. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364:141-148.
80. Xian CJ, Foster BK. 2006. Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy. Curr Stem Cell Res Ther 1:213-229.
81. Xu W, Zhang X, Qian H, Zhu W, Sun X, Hu J, Zhou H, Chen Y.2004.Mesenchymal stem cells from adult human bone marrow differentiate into acardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) 229:623-631.
82. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. 2001. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7:211-228.